Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome)
- 4 April 2023
- journal article
- research article
- Published by Springer Nature in BioDrugs
- Vol. 37 (3) , 375-395
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Site-specific chemical protein conjugation using genetically encoded aldehyde tagsNature Protocols, 2012
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and EfficacyThe AAPS Journal, 2012
- A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spotsMolecular Genetics and Metabolism, 2012
- Lysosomale Speichererkrankungen - Update und neue therapeutische OptionenKlinische Monatsblätter für Augenheilkunde, 2010
- Bisecting GlcNAc Residues on Laminin-332 Down-regulate Galectin-3-dependent Keratinocyte MotilityJournal of Biological Chemistry, 2010
- Genetic Engineering of a Bifunctional IgG Fusion Protein with Iduronate-2-SulfataseBioconjugate Chemistry, 2009
- Therapy for lysosomal storage disordersIUBMB Life, 2009
- Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis IEuropean Journal of Pediatrics, 2006
- Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Multiple forms of iduronate 2-sulphate sulphatase in human tissues and body fluidsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982